Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease by Sakiko Hiraoka, Shiho Takashima, Yoshitaka Kondo, Toshihiro Inokuchi, Yuusaku Sugihara, Masahiro Takahara, Seiji Kawano, Keita Harada, Jun Kato, Hiroyuki Okada

Subjects: Get full text

Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors by Chul Hwan Bang, Hyun Ju Oh, Yeong Ho Kim, Jin-Hyung Jung, Ji Hyun Lee, Young Min Park, Ju Hee Han

Subjects: Get full text

Ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis by Jennifer Albus Fehlman, MD, Nicole M. Burkemper, MD, Tricia A. Missall, MD, PhD

Subjects: “…anti–tumor necrosis factor-α inhibitors…”
Get full text

Successful Response to Golimumab in a Case of Relapsing Polychondritis Overlapping with Ulcerative Colitis by Kojima S, Matsumoto S, Koito Y, Miura T, Sekine M, Uehara T, Asano T, Yamaguchi Y, Mashima H

Subjects: Get full text

Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease by Tetsuya Ishida, Hideyasu Nagamatsu, Tetsuya Ueo, Ryoichi Narita, Ken Takahashi, Masaki Urabe, Yuka Yanai, Kazumi Togo

Subjects: Get full text

Improvement of DAS-28 ESR score in Egyptian children and adolescents with juvenile idiopathic arthritis treated with etanercept by Rasha Abdel-Raouf Afifi, Heba Taher Osman, Walaa Aboulkasem Shahin, Menna-t-allah Alaa ElDin Yousef

Subjects: Get full text

Vitiligo during Treatment of Crohn’s Disease with Adalimumab: Adverse Effect or Co-Occurrence by Celia Posada, Ángeles Flórez, Ana Batalla, Juan José Alcázar, Daniel Carpio

Subjects: Get full text

Immunological relationship between Helicobacter pylori and anti-tumor necrosis factor α agents in inflammatory bowel disease by Han Huang, Chenxiao Gan, Yan Cai, Lingkang Wu

Subjects: Get full text

Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study by Shettle L, McLaurin E, Martel J, Seaman JW III, Weissgerber G

Subjects: “…anti-tumor necrosis factor α…”
Get full text

Anti-NMDAR encephalitis in Crohn’s disease undergoing long-term infliximab treatment: A case report by Shin Ju Oh, Young Nam Kwon, Chang Kyun Lee, Jin San Lee

Subjects: Get full text

Protective effects of tumor necrosis factor-α blockade by adalimumab on articular cartilage and subchondral bone in a rat model of osteoarthritis by C.H. Ma, Q. Lv, Y.X. Yu, Y. Zhang, D. Kong, K.R. Niu, C.Q. Yi

Subjects: “…Anti-tumor necrosis factor-α antibody (ATNF)…”
Get full text

Protective effects of tumor necrosis factor-α blockade by adalimumab on articular cartilage and subchondral bone in a rat model of osteoarthritis by C.H. Ma, Q. Lv, Y.X. Yu, Y. Zhang, D. Kong, K.R. Niu, C.Q. Yi

Subjects: “…Anti-tumor necrosis factor-α antibody (ATNF)…”
Get full text

Case Report: Anti-TNF Treatment Failure in a Patient With Immune Checkpoint Inhibitor-Induced Severe Colitis by Leilei Fang, Changqin Liu, Xiaomin Sun, Zhanju Liu

Subjects: “…anti-tumor necrosis factor-α…”
Get full text